<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:hpo ids='HP_0011009'>Acute</z:hpo> <z:hpo ids='HP_0001942'>metabolic acidosis</z:hpo> is associated with increased morbidity and mortality because of its depressive effects on cardiovascular function, facilitation of <z:hpo ids='HP_0011675'>cardiac arrhythmias</z:hpo>, stimulation of <z:mp ids='MP_0001845'>inflammation</z:mp>, suppression of the immune response, and other adverse effects </plain></SENT>
<SENT sid="1" pm="."><plain>Appropriate evaluation of <z:hpo ids='HP_0011009'>acute</z:hpo> <z:hpo ids='HP_0001942'>metabolic acidosis</z:hpo> includes assessment of acid-base parameters, including pH, partial pressure of <z:chebi fb="0" ids="16526">CO(2)</z:chebi> and <z:chebi fb="0" ids="17544">HCO(3)(-)</z:chebi> concentration in arterial blood in stable patients, and also in central venous blood in patients with impaired tissue perfusion </plain></SENT>
<SENT sid="2" pm="."><plain>Calculation of the serum <z:chebi fb="5" ids="22563">anion</z:chebi> gap and the change from baseline enables the physician to detect organic acidoses, a common cause of severe <z:hpo ids='HP_0001942'>metabolic acidosis</z:hpo>, and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">aids</z:e> therapeutic decisions </plain></SENT>
<SENT sid="3" pm="."><plain>A fall in extracellular and intracellular pH can affect cellular function via different mechanisms and treatment should be directed at improving both parameters </plain></SENT>
<SENT sid="4" pm="."><plain>In addition to supportive measures, treatment has included administration of base, primarily in the form of <z:chebi fb="17" ids="32139">sodium bicarbonate</z:chebi> </plain></SENT>
<SENT sid="5" pm="."><plain>However, in clinical studies of <z:hpo ids='HP_0003128'>lactic acidosis</z:hpo> and <z:hpo ids='HP_0001993'>ketoacidosis</z:hpo>, bicarbonate administration has not reduced morbidity or mortality, or improved cellular function </plain></SENT>
<SENT sid="6" pm="."><plain>Potential explanations for this failure include exacerbation of intracellular <z:hpo ids='HP_0001941'>acidosis</z:hpo>, reduction in ionized Ca(2+), and production of <z:e sem="disease" ids="C0268009" disease_type="Disease or Syndrome" abbrv="">hyperosmolality</z:e> </plain></SENT>
<SENT sid="7" pm="."><plain>Administration of <z:chebi fb="0" ids="9754">tris(hydroxymethyl)aminomethane</z:chebi> (<z:chebi fb="0" ids="9754">THAM</z:chebi>) improves <z:hpo ids='HP_0001941'>acidosis</z:hpo> without producing intracellular <z:hpo ids='HP_0001941'>acidosis</z:hpo> and its value as a form of base is worth further investigation </plain></SENT>
<SENT sid="8" pm="."><plain>Selective <z:chebi fb="199" ids="26708">sodium</z:chebi>-hydrogen exchanger 1 (NHE1) inhibitors have been shown to improve haemodynamics and reduce mortality in animal studies of <z:hpo ids='HP_0011009'>acute</z:hpo> <z:hpo ids='HP_0003128'>lactic acidosis</z:hpo> and should also be examined further </plain></SENT>
<SENT sid="9" pm="."><plain>Given the important effects of <z:hpo ids='HP_0011009'>acute</z:hpo> <z:hpo ids='HP_0001942'>metabolic acidosis</z:hpo> on clinical outcomes, more intensive study of the pathogenesis of the associated cellular dysfunction and novel methods of treatment is indicated </plain></SENT>
</text></document>